STOCKHOLDERS’ DEFICIT (Details Narrative) - USD ($)
|
|
|
|
|
|
|
|
|
|
|
|
|
1 Months Ended |
3 Months Ended |
9 Months Ended |
12 Months Ended |
18 Months Ended |
20 Months Ended |
|
|
|
|
Aug. 01, 2024 |
Jul. 31, 2024 |
Jul. 01, 2024 |
May 13, 2024 |
Feb. 26, 2024 |
Jan. 26, 2024 |
Jan. 24, 2024 |
Jul. 20, 2023 |
May 09, 2023 |
Mar. 28, 2023 |
Feb. 10, 2023 |
Aug. 22, 2022 |
Aug. 31, 2024 |
Sep. 30, 2024 |
Jun. 30, 2024 |
Mar. 31, 2024 |
Sep. 30, 2023 |
Jun. 30, 2023 |
Sep. 30, 2024 |
Sep. 30, 2023 |
Mar. 31, 2024 |
Dec. 31, 2023 |
Dec. 31, 2022 |
Dec. 31, 2021 |
Sep. 30, 2024 |
Sep. 30, 2024 |
Nov. 14, 2024 |
Aug. 02, 2024 |
May 12, 2023 |
Jan. 26, 2023 |
| Subsidiary, Sale of Stock [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Common stock, shares authorized |
|
|
|
|
|
|
|
|
|
|
|
|
|
200,000,000
|
|
|
|
|
200,000,000
|
|
|
200,000,000
|
150,000,000
|
|
200,000,000
|
200,000,000
|
|
|
|
|
| Common stock, par value |
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 0.001
|
|
|
|
|
$ 0.001
|
|
|
$ 0.001
|
$ 0.001
|
|
$ 0.001
|
$ 0.001
|
|
|
|
|
| Exercise price |
|
|
|
|
|
|
|
|
|
|
|
$ 13.20
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Warrant term |
|
|
|
|
|
|
|
|
|
|
|
5 years
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Fair value of warrants |
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 92,000
|
|
|
|
|
$ 92,000
|
|
|
$ 1,651,000
|
$ 2,280,000
|
|
$ 92,000
|
$ 92,000
|
|
|
|
|
| Proceeds from issuance of common stock |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
202,000
|
|
|
|
|
|
|
|
|
| Warrants issued, fair value |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
3,984,000
|
|
|
|
|
|
|
|
| Issuance costs related to common stock issued under registered direct offering |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 39,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Common stock issued for entering into 2023 Equity Line of Credit Agreement |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 258,000
|
|
258,000
|
|
|
|
|
|
|
|
|
| Payment of issuance costs |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
134,000
|
|
|
|
|
|
|
|
|
| Stock issued during period value new issues |
|
|
|
|
|
|
|
|
|
|
|
|
|
400,000
|
1,101,000
|
$ 400,000
|
|
$ 178,000
|
|
|
|
1,177,000
|
|
|
|
|
|
|
|
|
| Proceeds from issuance of warrants |
|
$ 1,862,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Change in fair value of warrant liabilities |
|
|
|
|
|
|
|
|
|
|
|
|
|
(174,000)
|
|
|
$ 1,201,000
|
|
(1,314,000)
|
233,000
|
|
$ (629,000)
|
$ (1,704,000)
|
|
|
|
|
|
|
|
| Share based compensation shares reserved for issuance |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
165,861,000
|
|
248,613,000
|
|
|
|
|
|
|
| Weighted average exercise price of outstanding |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 17.48
|
$ 29.25
|
$ 44.40
|
|
|
|
|
|
|
| Weighted average remaining life |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
5 years 4 months 13 days
|
6 years 21 days
|
7 years 5 months 8 days
|
|
|
|
|
|
|
| Options outstanding |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
759,922,000
|
655,228,000
|
683,861,000
|
|
|
|
|
|
|
| Weighted average exercise price |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 6.57
|
$ 14.17
|
|
|
|
|
|
|
|
| Weighted average grant date fair value |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2 years
|
2 years
|
|
|
|
|
|
|
|
| Weighted average period over which unrecognized cost expected to be recognized |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
6 months
|
|
|
|
|
|
|
|
|
| Unvested Stock Option Awards [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Subsidiary, Sale of Stock [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Total unrecognized compensation costs related to nonvested stock option awards |
|
|
|
|
|
|
|
|
|
|
|
|
|
551,000
|
|
|
|
|
$ 551,000
|
|
|
$ 677,000
|
|
|
551,000
|
551,000
|
|
|
|
|
| Weighted average period over which unrecognized cost expected to be recognized |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1 year 11 months 12 days
|
|
|
1 year 9 months 21 days
|
|
|
|
|
|
|
|
|
| Restricted Stock [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Subsidiary, Sale of Stock [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Total unrecognized compensation costs related to nonvested stock option awards |
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 110,000
|
|
|
|
|
$ 110,000
|
|
|
$ 104,000
|
|
|
$ 110,000
|
$ 110,000
|
|
|
|
|
| Weighted average period over which unrecognized cost expected to be recognized |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
9 months
|
|
|
|
|
|
|
|
|
|
|
|
| Stock Incentive Plan 2010 [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Subsidiary, Sale of Stock [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Share based compensation shares reserved for issuance |
|
|
|
|
|
|
|
|
|
|
|
|
|
0
|
|
|
|
|
0
|
|
|
0
|
|
|
0
|
0
|
|
|
|
|
| Weighted average exercise price of outstanding |
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 28.11
|
|
|
|
|
$ 28.11
|
|
|
|
|
|
$ 28.11
|
$ 28.11
|
|
|
|
|
| Weighted average remaining life |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1 year 2 months 15 days
|
|
|
|
|
|
|
|
|
|
|
|
| Options outstanding |
|
|
|
|
|
|
|
|
|
|
|
|
|
45,360
|
|
|
|
|
45,360
|
|
|
245,154
|
|
|
45,360
|
45,360
|
|
|
|
|
| Stock Incentive Plan 2019 [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Subsidiary, Sale of Stock [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Share based compensation shares reserved for issuance |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
165,861
|
|
|
|
|
|
|
|
|
| Weighted average exercise price of outstanding |
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 7.15
|
|
|
|
|
$ 7.15
|
|
|
|
|
|
$ 7.15
|
$ 7.15
|
|
|
|
|
| Weighted average remaining life |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
8 years 4 months 24 days
|
|
|
|
|
|
|
|
|
|
|
|
| Share based compensation shares authorized for grants |
|
|
|
2,032,818
|
|
|
|
|
1,032,818
|
|
|
|
|
699,485
|
|
|
|
|
699,485
|
|
|
699,485
|
|
|
699,485
|
699,485
|
|
|
333,333
|
|
| Additional shares authorized |
|
|
|
1,000,000
|
|
|
|
|
333,333
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Options outstanding |
|
|
|
|
|
|
|
|
|
|
|
|
|
794,090
|
|
|
|
|
794,090
|
|
|
514,768
|
|
|
794,090
|
794,090
|
|
|
|
|
| RSUs outstanding |
|
|
|
|
|
|
|
|
|
|
|
|
|
153,750
|
|
|
|
|
153,750
|
|
|
59,463
|
|
|
153,750
|
153,750
|
|
|
|
|
| Common stock reserved for issuance |
|
|
|
|
|
|
|
|
|
|
|
|
|
642,865
|
|
|
|
|
642,865
|
|
|
|
|
|
642,865
|
642,865
|
|
|
|
|
| Weighted average grant date fair value |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 1.62
|
|
|
|
|
|
|
|
|
|
|
|
| Weighted average exercise price |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 2.68
|
|
|
|
|
|
|
|
|
|
|
|
| Interest rate, minimum |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
4.33%
|
|
|
|
|
|
|
|
|
|
|
|
| Interest rate, maximum |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
4.96%
|
|
|
|
|
|
|
|
|
|
|
|
| Forfeitures amount |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 13,000
|
|
|
|
|
|
|
|
|
|
|
|
| Securities Purchase Agreements [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Subsidiary, Sale of Stock [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Common stock shares issued |
|
|
|
|
|
|
|
|
|
|
|
|
9,733
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Stock issued during period value new issues |
|
|
|
|
|
|
|
|
|
|
|
|
$ 11,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Warrant Inducement Agreement [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Subsidiary, Sale of Stock [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Exercise price |
$ 1.25
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Warrants modification value |
|
$ 1,323,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Warrants exercised |
1,400,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 2022 Warrants [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Subsidiary, Sale of Stock [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Shares of common stock called by warrants |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
366,664
|
|
|
|
|
|
|
|
|
| Exercise price |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 13.20
|
| Change in fair value of warrant liabilities |
|
|
|
|
|
$ 106,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 2022 Warrants [Member] | Subsequent Event [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Subsidiary, Sale of Stock [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Shares of common stock called by warrants |
|
|
|
|
|
|
366,664
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Exercise price |
|
|
|
|
|
|
$ 13.20
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 2022 Amended Warrants [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Subsidiary, Sale of Stock [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Exercise price |
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 4.13
|
|
|
|
|
$ 4.13
|
|
|
$ 4.13
|
|
|
$ 4.13
|
$ 4.13
|
|
|
|
|
| Change in fair value of warrant liabilities |
|
|
|
|
|
$ 490,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 2022 Amended Warrants [Member] | Subsequent Event [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Subsidiary, Sale of Stock [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Exercise price |
|
|
|
|
|
|
4.13
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| August 2022 Warrants [Member] | Warrant Inducement Agreement [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Subsidiary, Sale of Stock [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Exercise price |
|
$ 4.13
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| January 2024 Warrants [Member] | Warrant Inducement Agreement [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Subsidiary, Sale of Stock [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Exercise price |
|
$ 4.13
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| July 2024 Warrants [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Subsidiary, Sale of Stock [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Shares issued price per share |
|
|
$ 1.53
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Additional Paid-in Capital [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Subsidiary, Sale of Stock [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Issuance costs related to common stock issued under registered direct offering |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
39,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Stock issued during period value new issues |
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 400,000
|
$ 1,100,000
|
$ 400,000
|
|
$ 178,000
|
|
|
|
$ 1,177,000
|
|
|
|
|
|
|
|
|
| Common Stock [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Subsidiary, Sale of Stock [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Common stock shares issued |
|
|
|
|
|
|
|
|
|
|
|
|
|
362,219
|
475,986
|
111,369
|
|
53,335
|
|
|
|
360,943
|
|
|
|
|
|
|
|
|
| Issuance costs related to common stock issued under registered direct offering |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Stock issued during period value new issues |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 1,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Common Stock [Member] | Stock Incentive Plan 2019 [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Subsidiary, Sale of Stock [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Options outstanding |
|
|
|
|
|
|
|
|
|
|
|
|
|
794,090
|
|
|
|
|
794,090
|
|
|
|
|
|
794,090
|
794,090
|
|
|
|
|
| Common Stock [Member] | August 2022 Warrants [Member] | Warrant Inducement Agreement [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Subsidiary, Sale of Stock [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Shares of common stock called by warrants |
|
311,111
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Common Stock [Member] | January 2024 Warrants [Member] | Warrant Inducement Agreement [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Subsidiary, Sale of Stock [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Shares of common stock called by warrants |
|
1,400,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Common Stock [Member] | August 2024 Warrants [Member] | Warrant Inducement Agreement [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Subsidiary, Sale of Stock [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Shares of common stock called by warrants |
|
2,566,667
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Warrant term |
|
5 years
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Common Stock [Member] | Chief Executive Officer [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Subsidiary, Sale of Stock [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Share price |
|
|
|
|
|
|
4.13
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Common Stock [Member] | Chief Executive Officer [Member] | Subsequent Event [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Subsidiary, Sale of Stock [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Share price |
|
|
|
|
|
|
$ 4.13
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Minimum [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Subsidiary, Sale of Stock [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Warrant restriction, threshold common stock held, percent |
|
|
|
|
|
|
|
|
|
|
|
4.99%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Minimum [Member] | Stock Incentive Plan 2019 [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Subsidiary, Sale of Stock [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Share price |
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 0.94
|
|
|
|
|
$ 0.94
|
|
|
|
|
|
$ 0.94
|
$ 0.94
|
|
|
|
|
| Weighted average grant date fair value |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1 year
|
|
|
|
|
|
|
|
|
|
|
|
| Maximum [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Subsidiary, Sale of Stock [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Warrant restriction, threshold common stock held, percent |
|
|
|
|
|
|
|
|
|
|
|
9.99%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Maximum [Member] | Stock Incentive Plan 2019 [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Subsidiary, Sale of Stock [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Share price |
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 4.87
|
|
|
|
|
$ 4.87
|
|
|
|
|
|
$ 4.87
|
$ 4.87
|
|
|
|
|
| Weighted average grant date fair value |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
3 years
|
|
|
|
|
|
|
|
|
|
|
|
| Stock Offering 2022 [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Subsidiary, Sale of Stock [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Common stock shares issued |
|
|
|
|
|
|
|
|
|
|
|
800,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Common stock, par value |
|
|
|
|
|
|
|
|
|
|
|
$ 0.001
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Common stock issuable per warrant |
|
|
|
|
|
|
|
|
|
|
|
799,985
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Shares of common stock called by warrants |
|
|
|
|
|
|
|
|
|
|
|
1
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Shares issued price per share |
|
|
|
|
|
|
|
|
|
|
|
$ 11.25
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Fair value of warrants |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 1,651,000
|
$ 2,280,000
|
|
|
|
|
|
|
|
| Proceeds from issuance of common stock |
|
|
|
|
|
|
|
|
|
|
|
$ 7,675,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Debt issuance costs |
|
|
|
|
|
|
|
|
|
|
|
1,325,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Warrants issued, fair value |
|
|
|
|
|
|
|
|
|
|
|
3,984,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Proceeds from issuance of equity |
|
|
|
|
|
|
|
|
|
|
|
9,000,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Warrants, offering costs |
|
|
|
|
|
|
|
|
|
|
|
$ 574,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Issuance costs related to common stock issued under registered direct offering |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 751,000
|
|
|
|
|
|
|
|
| Weighted average grant date fair value |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
3 years 7 months 20 days
|
4 years 7 months 20 days
|
|
|
|
|
|
|
|
| Purchase Agreement [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Subsidiary, Sale of Stock [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Common stock shares issued |
|
|
1,248,529
|
|
|
|
1,371,000
|
1,694,820
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Common stock, par value |
|
|
|
|
|
|
$ 0.001
|
$ 0.001
|
|
|
$ 0.001
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Shares issued price per share |
|
|
|
|
|
|
$ 0.0001
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Proceeds from issuance of common stock |
|
|
|
|
|
|
$ 5,563,000
|
$ 4,716,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Maximum aggregate offering price |
|
|
|
|
|
|
|
|
|
|
$ 12,500,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Payment of issuance costs |
|
|
$ 72,000
|
|
|
|
$ 733,000
|
$ 597,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Proceeds from issuance of private placement |
|
|
$ 1,910,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Purchase Agreement [Member] | Subsequent Event [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Subsidiary, Sale of Stock [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Common stock shares issued |
|
|
|
|
|
|
1,371,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Shares issued price per share |
|
|
|
|
|
|
$ 0.0001
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Proceeds from issuance of common stock |
|
|
|
|
|
|
$ 5,500,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Payment of issuance costs |
|
|
|
|
|
|
$ 941,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Purchase Agreement [Member] | July 2024 Warrants [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Subsidiary, Sale of Stock [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Exercise price |
|
|
$ 2.25
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Purchase Agreement [Member] | Pre Funded Warrants [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Subsidiary, Sale of Stock [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Shares of common stock called by warrants |
|
|
|
|
|
|
200,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Exercise price |
|
|
|
|
|
|
$ 0.0001
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Warrant restriction, threshold common stock held, percent |
|
|
|
|
|
|
9.99%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Proceeds from Warrant Exercises |
|
|
|
|
$ 20
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Purchase Agreement [Member] | Pre Funded Warrants [Member] | Subsequent Event [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Subsidiary, Sale of Stock [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Shares of common stock called by warrants |
|
|
|
|
|
|
200,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Exercise price |
|
|
|
|
|
|
$ 0.0001
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Warrant restriction, threshold common stock held, percent |
|
|
|
|
|
|
9.99%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Purchase Agreement [Member] | Purchase Warrants [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Subsidiary, Sale of Stock [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Shares of common stock called by warrants |
|
|
|
|
|
|
1,571,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Exercise price |
|
|
|
|
|
|
$ 4.13
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Warrant price |
|
|
|
|
|
|
$ 0.125
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Purchase Agreement [Member] | Purchase Warrants [Member] | Subsequent Event [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Subsidiary, Sale of Stock [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Shares of common stock called by warrants |
|
|
|
|
|
|
1,571,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Exercise price |
|
|
|
|
|
|
$ 4.13
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Warrant price |
|
|
|
|
|
|
$ 0.125
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Purchase Agreement [Member] | Investors [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Subsidiary, Sale of Stock [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Common stock shares issued |
|
|
|
|
|
|
1,368,600
|
1,650,473
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Share price |
|
|
|
|
|
|
$ 3.50
|
$ 2.75
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Purchase Agreement [Member] | Investors [Member] | Subsequent Event [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Subsidiary, Sale of Stock [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Common stock shares issued |
|
|
|
|
|
|
1,368,600
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Share price |
|
|
|
|
|
|
$ 3.50
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Purchase Agreement [Member] | Directors And Executive Officers [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Subsidiary, Sale of Stock [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Common stock shares issued |
|
|
|
|
|
|
|
44,347
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Share price |
|
|
|
|
|
|
|
$ 3.98
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Purchase Agreement [Member] | Chief Executive Officer [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Subsidiary, Sale of Stock [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Common stock shares issued |
|
|
|
|
|
|
2,400
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Shares issued price per share |
|
|
|
|
|
|
$ 4.255
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Purchase Agreement [Member] | Chief Executive Officer [Member] | Subsequent Event [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Subsidiary, Sale of Stock [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Common stock shares issued |
|
|
|
|
|
|
2,400
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Shares issued price per share |
|
|
|
|
|
|
$ 4.2555
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Purchase Agreement [Member] | Alliance Global Partners [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Subsidiary, Sale of Stock [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Common stock shares issued |
|
|
|
|
|
|
|
182,447
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Legal expenses |
|
|
|
|
|
|
$ 75,000
|
$ 75,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Placement agent cash fee paid |
|
|
|
|
|
|
7.00%
|
7.00%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Non accountable expense allowance |
|
|
|
|
|
|
$ 30,000
|
$ 30,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Placement agent cash fee |
|
|
|
|
|
|
3.50%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Purchase Agreement [Member] | Alliance Global Partners [Member] | Subsequent Event [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Subsidiary, Sale of Stock [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Legal expenses |
|
|
|
|
|
|
$ 75,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Placement agent cash fee paid |
|
|
|
|
|
|
7.00%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Non accountable expense allowance |
|
|
|
|
|
|
$ 30,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Placement agent cash fee |
|
|
|
|
|
|
3.50%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Purchase Agreement [Member] | Alliance Global Partners [Member] | Directors And Executive Officers [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Subsidiary, Sale of Stock [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Placement agent cash fee paid |
|
|
|
|
|
|
|
3.50%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Placement Shares [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Subsidiary, Sale of Stock [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Common stock shares issued |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
0
|
|
|
35,552
|
|
|
|
35,552
|
|
|
|
|
| Proceeds from issuance of common stock |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 211,000
|
|
|
|
$ 211,000
|
|
|
|
|
| Issuance costs related to common stock issued under registered direct offering |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 134,000
|
|
|
134,000
|
|
|
|
|
|
|
|
|
| Placement fee, percentage |
|
|
|
|
|
|
|
|
|
|
3.00%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Prepaid stock issuance costs |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
0
|
$ 150,000
|
|
|
|
|
|
|
|
| General and administrative expense |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
143,000
|
|
|
|
|
|
|
|
|
| Payment of issuance costs |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 0
|
|
|
|
|
|
|
|
|
|
|
|
| Placement Shares [Member] | Additional Paid-in Capital [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Subsidiary, Sale of Stock [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Offset of additional paid in capital |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 7,000
|
|
|
|
|
|
|
|
|
| LPC Purchase Agreement [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Subsidiary, Sale of Stock [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Common stock, par value |
|
|
|
|
|
|
|
|
|
$ 0.001
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Purchase Shares [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Subsidiary, Sale of Stock [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Maximum aggregate offering price |
|
|
|
|
|
|
|
|
|
$ 10,000,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 2023 Equity Line of Credit Agreement [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Subsidiary, Sale of Stock [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Common stock shares issued |
|
|
|
|
|
|
|
|
|
|
|
|
|
362,219
|
|
|
|
|
949,574
|
|
472,312
|
360,943
|
|
|
1,310,517
|
|
|
|
|
|
| Proceeds from issuance of common stock |
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 400,000
|
|
|
|
|
$ 1,900,000
|
|
$ 1,578,000
|
$ 1,177,000
|
|
|
$ 3,078,000
|
|
|
|
|
|
| Purchase agreement term |
|
|
|
|
|
|
|
|
|
36 months
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Maximum number of shares per purchase |
|
|
|
|
|
|
|
|
|
6,667
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Stock issuance expenses |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
326,000
|
|
|
329,000
|
|
|
|
|
|
|
|
|
| Common stock issued for entering into 2023 Equity Line of Credit Agreement |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
258,000
|
|
|
258,000
|
|
|
|
|
|
|
|
|
| Legal expenses |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
249,000
|
38,000
|
|
41,000
|
|
|
|
|
|
|
|
|
| 2023 Equity Line of Credit Agreement [Member] | Lincoln Park Capital Fund [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Subsidiary, Sale of Stock [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Common stock shares issued |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
47,733
|
|
|
|
|
|
|
|
|
|
| Stock transaction costs |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
30,000
|
|
|
$ 30,000
|
|
|
|
|
|
|
|
|
| 2023 Equity Line of Credit Agreement [Member] | Minimum Share Purchase Stock Price Range One [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Subsidiary, Sale of Stock [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Maximum number of shares per purchase |
|
|
|
|
|
|
|
|
|
13,333
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Share price |
|
|
|
|
|
|
|
|
|
$ 7.50
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 2023 Equity Line of Credit Agreement [Member] | Minimum Share Purchase Stock Price Range Two [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Subsidiary, Sale of Stock [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Maximum number of shares per purchase |
|
|
|
|
|
|
|
|
|
16,666
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Share price |
|
|
|
|
|
|
|
|
|
$ 11.25
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 2023 Equity Line of Credit Agreement [Member] | Minimum Share Purchase Stock Price Range Three [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Subsidiary, Sale of Stock [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Maximum number of shares per purchase |
|
|
|
|
|
|
|
|
|
20,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Share price |
|
|
|
|
|
|
|
|
|
$ 15.00
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 2023 Equity Line of Credit Agreement [Member] | Maximum [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Subsidiary, Sale of Stock [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Maximum number of shares per purchase |
|
|
|
|
|
|
|
|
|
$ 1,000,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 2023 Equity Line of Credit Agreement [Member] | Maximum [Member] | Lincoln Park Capital Fund [Member] | Subsequent Event [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Subsidiary, Sale of Stock [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Remaining value of shares to be sold under the agreement |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 1,700,000
|
|
|
|
| At The Market Offering Agreement [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Subsidiary, Sale of Stock [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Proceeds from issuance of common stock |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
202,000
|
|
|
|
|
|
|
|
|
|
|
| Payment of issuance costs |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 134,000
|
|
|
|
|
|
|
|
|
|
|
| Number of share common stock sold |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
0
|
|
|
|
|
|
|
|
|
|
|
|
| At The Market Offering Agreement [Member] | HC Wainwright Co [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Subsidiary, Sale of Stock [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Common stock maximum aggregate sales price |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 4,450,000
|
|
|
| Percentage of commission rate equal to gross proceeds from sale of shares |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
3.00%
|
|
|